本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

15.51
+0.16001.04%
盤後15.510.00000.00%19:30 EDT
成交量:112.72萬
成交額:1,758.25萬
市值:18.06億
市盈率:-11.86
高:16.00
開:15.50
低:15.35
收:15.35
52周最高:21.45
52周最低:9.82
股本:1.16億
流通股本:9,642.36萬
量比:1.09
換手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
淨資產收益率:-43.22%
總資產收益率:-9.26%
市淨率:5.34
市盈率(LYR):-12.69

資料載入中...

2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/22

重要事件披露

Form 8-K - Current report
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities